Connor, Clark & Lunn Investment Management (CC&L)
PSTX

Connor, Clark & Lunn Investment Management (CC&L)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$1.47M Sell
2024
Q3 		$1.03M Buy
2024
Q2 		$644K Sell
2024
Q1 		$1.61M Buy
2023
Q4 		$1.26M Buy
2023
Q3 		$816K Buy
2023
Q2 		$210K Buy